<DOC>
<DOCNO>
EP-0000272
</DOCNO>
<TEXT>
<DATE>
19790110
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07D-501/36</main> C07D-257/04 A61P-31/00 A61K-31/545 C07D-257/00 C07D-501/36 A61K-31/546 C07D-501/00 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
7-acylamino-3-substituted-3-cephem-4-carboxylic acids, processes for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
smithkline corpus<sep>smithkline corporation<sep>smithkline beckman corporationp.o. box 7929 1 franklin plazaphiladelphia pennsylvania 19101us<sep>smithkline beckman corporation<sep>
</APPLICANT>
<INVENTOR>
berges davis alan<sep>berges, davis alan<sep>berges, davis alan18, buckwalter roadphoenixville pennsylvania 19460us<sep>berges, davis alan<sep>berges, davis alan18, buckwalter roadphoenixville pennsylvania 19460us<sep>
</INVENTOR>
<ABSTRACT>
cephalosporins with the formula    in which r represents various acyl substituents;   n represents 2-4, preferably 2,   n′ represents 1-4, preferably 1,   r′ represents hydrogen or lower alkyl from one to  four carbons, show antibacterial activity.  they can be prepared by reacting the corresponding  3-acetoxy- methyl cephalosporin with the appropriate  carboxyalkylamino-alkyltetrazolethione.  the tetrazolethiones  used as intermediates also form part of the  invention.  
</ABSTRACT>
</TEXT>
</DOC>
